For pharmaceutical companies, patient safety has always been the priority. That’s why pyrogen detection has become a mandatory Quality Control test for release of any parenteral drug. With the Monocyte Activation Test, the only in vitro test for the detection of the full range of pyrogens (including endotoxin and non-endotoxin pyrogens), it’s now time to move away from animal-based test for pyrogen detection. The new PyroMAT® system provides pharma companies with a robust solution to make the move to in vitro Pyrogen Test with a ready-to use kit!
Laure Robert
MilliporeSigma
Global Product Manager
Anja Fritsch
Confarma, France
Chief Scientific Officer
Microbiological testing
Duration:14min
Language:English
Session 1:presented October 25, 2018
To continue reading please sign in or create an account.
Don't Have An Account?